Ø Patients ≤ 40 years and ≥ 70 years of age.
Ø Known cases of Gout, Rheumatoid Arthritis, Systemic Lupus Erythematous (SLE), Bone TB, Traumatic injuries, Infective arthritis and other serious systemic disorder.
Ø Patient is not indicated for Snehana and Swedana.
Ø Patient is unfit for Matra Basti (eg. Raktarsha , Bhagandar etc.)
Ø Patient having history of knee joint replacement.
STUDY DESIGN:
Ø STUDY TYPE : Open Labelled Randomized Clinico Comparative Trail
Ø BLINDING : Open label
Ø COMPARATIVE : Yes
Ø NO. OF GROUP : 2
GROUP-1: Will be treated with Devdarubaladi Taila Matra Basti.
GROUP-2: Will be treatd with Balasaireyaka Taila Matra Basti.
Ø SAMPLE SIZE : Minimum 15 patients will be include in each group.
Ø LOCATION OF STUDY : Study will be conducted at Government Akhandanand Ayurved Hospital ,Ahmedabad and Maniben Ayurved Hospital.
The patients will be randomly divided into two groups irrespective of their Age, Gender, Religion and Occupation.
Group-A : Devdarubaladi Taila Matra Basti for 15 days.
Group-B: Balasaireyaka Taila Matra Basti for 15 days.
INVESTIGATIONS:
Ø Haematological examination: HB%, CBC (Both B.T. and A.T.), ESR
Ø RBS, RA, Uric Acid (To rule out other pathologies).
Ø Radiological Assessment: Plain X-ray AP and Lateral view- standing position (Both B.T. and A.T.).
WITHDRAWAL CRITERIA:
After the scheduled course, medicines will be withdrawan with proper consultation and future follow up will be maintained. During the trail period, if any moderate to severe complications found, medication will be stopped.
CRITERIA FOR ASSESSMENT:
Ø By observing clinical improvement in signs and symptoms of disease mentioned in Ayurvedic classics as well as modern texts.
Ø To assess the effect of therapy objectively, all the signs and symptoms like Sandhishula, Sandhishotha , Akunchan prasarne Vedana, Sandhisphutuna (Crepitation) will be subjected to given scoring patterns.
Ø Assessment will be done before treatment and after completion of entire treatment.
REPORTING A.D.R:
Adverse Drug Reaction (ADR), if observed will be registered and reported to Peripheral Pharmacovigilance Center (PPvC), GAAC, Ahemdabad.
STATISTICAL ANALYSIS:
Assessment will be done on the basis of special proforma through scoring pattern and will be analysed statistically with help of “t†test and Willcoxon signed-rank test. where > 0.05=insignificant result, < 0.05 = significant result and < 0.001= highly significant result.
STANDARD PROFORMA:
Standard proforma will be developed and used in the study to evaluate the comparative efficacy of the trail drug.
PRESENTATION OF DATA: The data collected, analysed will be depicted as general observations viz. age, sex, religion etc. The results of individual investigations will be presented by a proper bar diagram, pie diagram etc.
DISCUSSTION AND CONCLUSION:
After getting all the data, discussion and conclusion will be done as per the observations and results.
COLLABORATION REQUIRED: With other Department
Department of RSBK, Dravyaguna and Roganidan-Vikruti Vigyan Department Government Akhandanad Ayurved Collage, Ahmedabad.
DECLARATION: The study will be completed in the stipulated time limit. The work will be carried out after getting clearance from the institutional ethics committee. The data related to the identification of the patient will be kept confidential. The clinical data obtained will be summarized at the end of the study.